The global hydroxychloroquine market is expected to witness substantial CAGR from 2020 to 2030. The market growth can be attributed to several factors, which has led toits wide-scale adoption. Growing prevalence of malaria and increasing demand of hydroxychloroquine drug worldwide for the treatment of COVID-19are anticipated to fuel its demand. However, restrictions on its purchase ever since it has been considered for the treatment of newly discovered disease COVID-19 is likely to restrain the market growth to a certain extent.
Hydroxychloroquine Market Prominent Players:
Some of the prominent players operating in the hydroxychloroquine market are Sanofi, Novartis AG, Ipca Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila, Lupin Pharmaceuticals, Inc., DR. REDDY’S LABORATORIES LTD., Bristol Laboratories Ltd, Mylan N.V., Teva Pharmaceuticals USA, Inc., among others.
No comments:
Post a Comment